Introduction

Shamrock Pharmachemi is a part of Shamrock Group, which is involved in Contract Manufacturing, and export of APIs, Intermediates and Veterinary products for over 23 years. Over this period Shamrock has established itself as a recognizable brand promoting Indian APIs and Intermediates internationally.

Historical milestone achieved indicates the company’s strength in penetrating markets and customers easily than the biggest Pharma giants can ever fathom in spite of having young guns in their team. Shamrock believes “Together We Can Improve the Quality of Life” world over making a difference & enhancing customer satisfaction in the process improving health care solutions thereby transforming the lives of millions.

Our business model includes Exclusive Manufacturing, Contract Manufacturing and Outsourcing. We maintain the highest quality standards backed by complete Regulatory Approval and Documentation – cGMP, EUGMP, WHOGMP, FDA with DMF, CTD Dossiers, CEP etc. and these are provided to our customers along with quality audits by independent approved auditors.

Years of experience
in pharmaceutical industry

DMFS filed in
Regulatory markets

CEPs

Number of APIs

Country exporting currently

Manufacturing Facilities
Owned-4
Partnership-4

MEET US AT CPHI MILAN 2026 | 6–8 OCTOBER | HALL 2 | STAND F66

Pioneered International Export Marketing and Sales from India on a long term Contract Manufacturing basis with Overseas Generic FDA Approved producers.

Pioneers in entering South American Market, Brazil, Argentina, Georgia, Paraguay, Colombia & Mexico.

Entered Iraq Market & obtained Tender Business with $80 Million. 1st company from India to Transfer Technology from India to API Stage with Buy Back Agreement.

Similarly, 1st Company from India to Transfer Finished Products Technology against Buy Back of API’s with the Regulatory Documentation.

1st Company from India to enter Iran Market for Intermediates with Technology Transfer and Buy Back Agreements.

Successfully convinced the European Customers to beat the Chinese competitions by convincing them to approach Non-Chinese source/Indian source for their safety.

Our company a proud recipient of the “Outstanding Export Performance Award For 2017” by ‘Pharmexcil’, [A Pharmaceutical Export Promotion Council] Govt. of India.

First Export Marketing Company in India to have R&D and Technical Development and Technology Transfer with Regulatory Support with DMF, COS and USFDA approval.

Largest Contract Manufacturing and Export of Specialty Key Intermediates from India.

Largest Exporter of: – Pharmaceutical Grade PC – Lecithin – Anti-hyperphosphopamic API – Lovastatin (Fermentation) Exported over 400 tons.

Partnership agreement contracted with 12 Manufacturing units across India.

Ventured into 100% Manufacturing Facilities. With the best machinery equipped with regulatory compliance we have set up 2 Manufacturing units Gujarat, India. Ventured in Manufacturing with its Pilot Plant, greenfield project in 2020.

Meet Shamrock Pharma Group & Unimark Remedies to explore partnership opportunities across Specialty APIs, Carbapenem APIs, Sterile APIs, Critical Care FDFs, Regulated-Market APIs, Biologics, CMO/CDMO, Technology Transfer and Non-China Supply Solutions.

MEETING OPPORTUNITIES

Whether you are evaluating new suppliers, developing new products or seeking a reliable long-term manufacturing partner, we look forward to meeting you at CPHI Milan 2026.

BOOK A MEETING

Drop us an Email at

Unimark Remedies :- marketing@unimarkremedies.com

Shamrock Pharma Group :-pharma@shamrockindia.com

Partnership & Alliances :- globalops@shamrockpharmagroup.com